EUVIMEDEUVIMED entdecken
Crossref

Risk of SARS-CoV-2 infection and adverse outcomes among vaccinated patients with tuberculosis

Renin Chang, Sheng-Yin Chen, Tina Yi-Jin Hsieh, Hui-Yuan Chen, Shiow-Ing Wang, Yao-Min Hung, James Cheng-Chung Wei

Public Health · 2025

DOI: 10.1016/j.puhe.2024.09.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health, 2025. Verfasst von Renin Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Recreation and Sports Management,…. Hauptthemen laut MEDLINE: COVID-19, Tuberculosis, COVID-19 Vaccines. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Science and Technology Council, Chung Shan Medical University Hospital, Kaohsiung Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Limited data are available to assess breakthrough SARS-CoV-2 infections, medical utilization, and mortality in patients with tuberculosis (TB). The aim of this study was to examine the risk of COVID-19 and severe outcomes in patients with TB between January 2020 and March 2022. STUDY DESIGN: US electronic medical records were used to identify TB and non-TB patients who completed the primary series of vaccination and had no prior COVID-19. METHODS: Breakthrough infections and severe adverse outcomes, defined by the Centers for Disease Control and Prevention as hospitalization, need for mechanical ventilation and/or intensive care unit admission, or in-hospital mortality, following a positive SARS-CoV-2 polymerase chain reaction (PCR) test. Follow-up began 14 days after the primary vaccination series was completed and continued for 365 days. RESULTS: The study included 15,541 TB and 15,541 non-TB patients. The risk of breakthrough infection was significantly higher in the TB group than in the non-TB group after controlling for age, sex, ethnicity, socioeconomic status, and lifestyles (adjusted HR, 1.444; 95 % CI, 1.321-1.579). Similar trends were observed in pre-specified subgroup analyses stratified by age, sex, and status of TB. Patients in the TB group had higher risks of emergency room visit and critical care admission [adjusted HRs, 1.244 (95 % CI, 1.175-1.316) and 1.404 (95 % CI, 1.182-1.668)]. CONCLUSIONS: Our study revealed a higher risk of COVID-19 breakthrough infections and adverse outcomes among patients with TB. Thus, besides priority COVID-19 vaccination, healthcare providers should continue vigilance for patients with TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19TuberculosisCOVID-19 VaccinesHumansFemaleMaleMiddle AgedAdultAgedHospitalizationSARS-CoV-2United StatesRisk FactorsHospital MortalityRespiration, ArtificialBreakthrough Infections

Stichwörter der Autor:innen

Breakthrough infectionCOVID-19Cohort studyTuberculosisVaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Recreation and Sports Management, Tajen University, Pintung, Taiwan; School of Medicine, Chung Shan Med…
  • Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston,…
  • Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, USA; Department of Bioinformatics, Harvard…
  • Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Electronic address: laura812630@gmail.com.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Center for Health Data Science, Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: shiow…
  • Department of Internal Medicine, Taitung Hospital, Ministry of Health and Welfare, Taitung, Taiwan; Master Program in Biomedicine, College of Science and Engineering, National Taitung University, Taitung, Taiwan; Colleg…

Förderung

  • National Science and Technology Council
  • Chung Shan Medical University Hospital
  • Kaohsiung Veterans General Hospital

Zitieren

APA

Chang, R., Chen, S. Y., Hsieh, T. Y., Chen, H. Y., Wang, S. I., Hung, Y. M., & Wei, J. C. (2025). Risk of SARS-CoV-2 infection and adverse outcomes among vaccinated patients with tuberculosis. Public Health. https://doi.org/10.1016/j.puhe.2024.09.028

Vancouver

Chang R, Chen SY, Hsieh TY, Chen HY, Wang SI, Hung YM, et al. Risk of SARS-CoV-2 infection and adverse outcomes among vaccinated patients with tuberculosis. Public Health. 2025. doi:10.1016/j.puhe.2024.09.028

BibTeX
@article{Chang2025,
  author = {Chang, Renin and Chen, Sheng-Yin and Hsieh, Tina Yi-Jin and Chen, Hui-Yuan and Wang, Shiow-Ing and Hung, Yao-Min and Wei, James Cheng-Chung},
  title = {Risk of SARS-CoV-2 infection and adverse outcomes among vaccinated patients with tuberculosis},
  journal = {Public Health},
  year = {2025},
  doi = {10.1016/j.puhe.2024.09.028}
}
Kostenlos starten →